Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Shock, HemorrhagicShock, TraumaticAcidosis, Lactic
Interventions
DRUG

MP4OX

4.3 g/dL PEG-Hb solution in lactated electrolyte solution

DRUG

MP4OX

4.3 g/dL PEG-Hb solution in lactated electrolyte solution

DRUG

Ringers Lactate solution

Ringers Lactate solution for Injection

Trial Locations (13)

Unknown

Centre Hospitalier de Bicêtre, Le Kremlin-Bicêtre

CHRU de Lille - Hôpital Claude Huriez, Lille

Hôpital Dupuytren, Limoges

Hôpital Pitié-Salpêtrière, Paris

Charité Campus Virchow Klinikum, Berlin

Klinikum der Johann-Wolfgang-Goethe-Universität, Frankfurt

Netcare Union Hospital, Alberton

Charlotte Maxeke Johannesburg Hospital, Johannesburg

Netcare Milpark Hospital, Johannesburg

Netcare Unitas Hospital, Centurian, Pretoria

Steve Biko Academic Hospital, Pretoria

Chris Hani Baragwanath Hospital, Soweto

The Royal London Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sangart

INDUSTRY